![](/img/cover-not-exists.png)
492PA multicenter phase II trial to evaluate the efficacy of mFOLFOX6+cetuximab as induction chemotherapy to achieve R0 surgical resection for advanced colorectal liver metastases (NEXTO trial)
Nishioka, Y, Hasegawa, K, Saiura, A, Oba, M, Yamamoto, J, Nomura, Y, Takayama, T, Hashiguchi, Y, Shibasaki, M, Sakamoto, H, Yamagata, S, Aoyanagi, N, Kaneko, H, Koyama, H, Miyagawa, S, Mise, Y, ShinozVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy281.039
Date:
October, 2018
File:
PDF, 93 KB
2018